| A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B TT Chang, RG Gish, R De Man, A Gadano, J Sollano, YC Chao, AS Lok, ... New England Journal of Medicine 354 (10), 1001-1010, 2006 | 2063 | 2006 |
| Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial D Lebrec, N Giuily, A Hadengue, V Vilgrain, R Moreau, T Poynard, ... Journal of hepatology 25 (2), 135-144, 1996 | 527 | 1996 |
| Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B RG Gish, AS Lok, TT Chang, RA De Man, A Gadano, J Sollano, KH Han, ... Gastroenterology 133 (5), 1437-1444, 2007 | 511 | 2007 |
| Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide S Piano, V Singh, P Caraceni, R Maiwall, C Alessandria, J Fernandez, ... Gastroenterology 156 (5), 1368-1380. e10, 2019 | 398 | 2019 |
| The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report N Antaki, A Craxi, S Kamal, R Moucari, S Van der Merwe, S Haffar, ... Liver International 30 (3), 342-355, 2010 | 270 | 2010 |
| Beneficial effects of the 2-day administration of terlipressin in patients with cirrhosis and hepatorenal syndrome A Hadengue, A Gadano, M Richard, E Giostra, F Durand, D Valla, ... Journal of hepatology 29 (4), 565-570, 1998 | 265 | 1998 |
| Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B ER Schiff, SS Lee, YC Chao, SK Yoon, F Bessone, SS Wu, W Kryczka, ... Clinical Gastroenterology and Hepatology 9 (3), 274-276. e1, 2011 | 245 | 2011 |
| Safety and efficacy of oral entecavir given for 28 days in patients with chronic hepatitis B virus infection RA de Man, LMM Wolters, F Nevens, D Chua, M Sherman, CL Lai, ... Hepatology 34 (3), 578-582, 2001 | 231 | 2001 |
| The present and future disease burden of hepatitis C virus (HCV) infections with today's treatment paradigm–volume 2 A Hatzakis, V Chulanov, AC Gadano, C Bergin, Z Ben‐Ari, J Mossong, ... Journal of viral hepatitis 22, 26-45, 2015 | 184 | 2015 |
| Efficacy of entecavir with or without tenofovir disoproxil fumarate for nucleos (t) ide-naive patients with chronic hepatitis B AS Lok, H Trinh, G Carosi, US Akarca, A Gadano, F Habersetzer, ... Gastroenterology 143 (3), 619-628. e1, 2012 | 183 | 2012 |
| Loss of HBsAg antigen during treatment with entecavir or lamivudine in nucleoside‐naive HBeAg‐positive patients with chronic hepatitis B RG Gish, TT Chang, CL Lai, R De Man, A Gadano, F Poordad, J Yang, ... Journal of viral hepatitis 17 (1), 16-22, 2010 | 170 | 2010 |
| Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: a retrospective study R Terg, A Gadano, M Cartier, P Casciato, R Lucero, A Muñoz, G Romero, ... Liver International 29 (3), 415-419, 2009 | 154 | 2009 |
| Spontaneous bacterial peritonitis in patients with cirrhosis: incidence, outcomes, and treatment strategies S Marciano, JM Diaz, M Dirchwolf, A Gadano Hepatic medicine: evidence and research, 13-22, 2019 | 142 | 2019 |
| Historical epidemiology of hepatitis C virus (HCV) in select countries–volume 2 V Saraswat, S Norris, RJ De Knegt, JF Sanchez Avila, M Sonderup, ... Journal of viral hepatitis 22, 6-25, 2015 | 142 | 2015 |
| Proton pump inhibitor therapy does not increase the incidence of spontaneous bacterial peritonitis in cirrhosis: a multicenter prospective study R Terg, P Casciato, C Garbe, M Cartier, T Stieben, M Mendizabal, ... Journal of hepatology 62 (5), 1056-1060, 2015 | 140 | 2015 |
| Chronic hepatitis B: current epidemiology in the Americas and implications for management RG Gish, AC Gadano Journal of viral hepatitis 13 (12), 787-798, 2006 | 130 | 2006 |
| Beneficial hemodynamic effects of bosentan, a mixed ETA and ETB receptor antagonist, in portal hypertensive rats P Sogni, R Moreau, A Gomola, A Gadano, S Cailmail, Y Calmus, M Clozel, ... Hepatology 28 (3), 655-659, 1998 | 127 | 1998 |
| Hypoxemia in patients with cirrhosis: relationship with liver failure and hemodynamic alterations F Vachiéry, R Moreau, A Hadengue, A Gadano, T Soupison, D Valla, ... Journal of hepatology 27 (3), 492-495, 1997 | 126 | 1997 |
| Imatinib-induced fatal acute liver failure E Ridruejo, R Cacchione, AG Villamil, S Marciano, AC Gadano, ... World journal of gastroenterology: WJG 13 (48), 6608, 2007 | 119 | 2007 |
| The role of nitric oxide in the hyperdynamic circulatory syndrome associated with portal hypertension P Sogni, R Moreau, A Gadano, D Lebrec Journal of hepatology 23 (2), 218-224, 1995 | 119 | 1995 |
